Filed: 2/14/2024ACC: 0000919574-24-001188
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $18.52M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$18.52M
Total AUM (reported)
7.57M
Total Shares
Allocation by class
COM$15.40M83.1%
COM NEW$1.95M10.5%
TR UNIT$628.1K3.4%
CL B NEW$369.3K2.0%
SPONSORED ADS$179.1K1.0%
Portfolio Concentration
Top 3$16.23M87.6%
4–10$2.16M11.7%
11–25$135.3K0.7%
Top 3 weight
87.6%
Top 10 weight
99.3%
Voting Authority Distribution
Total shares with voting rights: 7.57M
Sole
Full voting authority
7.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
XERIS BIOPHARMA HOLDINGS INC
SOLEShares5.64M
TypeSH
Market value$13.26M
71.57%
Sole
5.64M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares353.44K
TypeSH
Market value$1.66M
8.97%
Sole
353.44K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.32M
TypeSH
Market value$1.31M
7.07%
Sole
1.32M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares1.32K
TypeSH
Market value$628.1K
3.39%
Sole
1.32K
Shared
0.00
None
0.00
MOLECULAR TEMPLATES INC
SOLEShares136.87K
TypeSH
Market value$510.5K
2.76%
Sole
136.87K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares1.03K
TypeSH
Market value$369.3K
1.99%
Sole
1.03K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares7.35K
TypeSH
Market value$205.4K
1.11%
Sole
7.35K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares16.74K
TypeSH
Market value$179.1K
0.97%
Sole
16.74K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares10.32K
TypeSH
Market value$138.5K
0.75%
Sole
10.32K
Shared
0.00
None
0.00
HARPOON THERAPEUTICS INC
SOLEShares13.18K
TypeSH
Market value$129.3K
0.70%
Sole
13.18K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares43.47K
TypeSH
Market value$67.8K
0.37%
Sole
43.47K
Shared
0.00
None
0.00
ALLAKOS INC
SOLEShares24.71K
TypeSH
Market value$67.5K
0.36%
Sole
24.71K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 5.64M | SH | $13.26M 71.57% | 5.64M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 353.44K | SH | $1.66M 8.97% | 353.44K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.32M | SH | $1.31M 7.07% | 1.32M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 1.32K | SH | $628.1K 3.39% | 1.32K | 0.00 | 0.00 |
MOLECULAR TEMPLATES INCSOLE | COM NEW | 136.87K | SH | $510.5K 2.76% | 136.87K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 1.03K | SH | $369.3K 1.99% | 1.03K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 7.35K | SH | $205.4K 1.11% | 7.35K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 16.74K | SH | $179.1K 0.97% | 16.74K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 10.32K | SH | $138.5K 0.75% | 10.32K | 0.00 | 0.00 |
HARPOON THERAPEUTICS INCSOLE | COM NEW | 13.18K | SH | $129.3K 0.70% | 13.18K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 43.47K | SH | $67.8K 0.37% | 43.47K | 0.00 | 0.00 |
ALLAKOS INCSOLE | COM | 24.71K | SH | $67.5K 0.36% | 24.71K | 0.00 | 0.00 |